Different methods and settings for glucose monitoring for gestational diabetes during pregnancy

Raman, Puvaneswary; Shepherd, Emily; Dowswell, Therese; Middleton, Philippa; Crowther, Caroline A

doi:10.1002/14651858.cd011069.pub2

Cited by 41 publications

(60 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is growing evidence in support of the impact of mHealth interventions on the management of diabetes [ 26 , 38 ]. However, given that there is as large variety of different mHealth tools currently available, the most effective method and setting for the management of GDM remain unclear [ 39 ]. A previous systematic review concluded that there was insufficient evidence showing that the use of telemedicine technology was superior to the use of the standard care procedure for women with GDM [ 39 ].…”

Section: Discussionmentioning

confidence: 99%

Health Care Professionals’ Attitudes Toward, and Experiences of Using, a Culture-Sensitive Smartphone App for Women with Gestational Diabetes Mellitus: Qualitative Study

Garnweidner-Holme¹,

Andersen²,

Sando³

et al. 2018

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

BackgroundThe increasing prevalence of gestational diabetes mellitus (GDM) among women of different ethnic backgrounds provides new challenges for health care professionals, who often find it difficult to provide information about the management of this disease to such individuals. Mobile health (mHealth) may act as a useful tool for blood sugar control and care process enhancement. However, little is known about health care professionals’ experiences and attitudes toward the use of mHealth for women with GDM.ObjectiveThe aim of this study was to explore how health care professionals perceived the provision of care to pregnant women who managed their GDM using the culture-sensitive Pregnant+ app in a randomized controlled trial.MethodsIndividual interviews with 9 health care professionals providing care for women with GDM were conducted. Braun and Clark’s method of thematic content analysis inspired the analysis. This study included health care professionals who were primarily responsible for providing care to participants with GDM in the Pregnant+ randomized controlled trial at 5 diabetes outpatient clinics in Oslo, Norway.ResultsHealth care professionals perceived mHealth, particularly the Pregnant+ app, as an appropriate tool for the care of women with GDM, who were described as individuals comprising a heterogeneous, motivated group that could be easily approached with health-related information. Some participants reported challenges with respect to provision of advice to women with different food cultures. The advantages of the Pregnant+ app included provision of information that women could access at home, the information provided being perceived as trustworthy by health care professionals, the culture sensitivity of the app, and the convenience for women to register blood sugar levels. Technical problems, particularly those associated with the automatic transfer of blood glucose measurements, were identified as the main barrier to the use of the Pregnant+ app. Strict inclusion criteria and the inclusion of participants who could not speak Norwegian were the main challenges in the recruitment process for the randomized controlled trial.ConclusionsThe findings of this study suggest that mHealth is a useful tool to enhance the care provided by health care professionals to women with GDM. Future mobile apps for the management of GDM should be developed by a trustworthy source and in cooperation with health care professionals. They should also be culture sensitive and should not exhibit technical problems.

show abstract

Section: Discussionmentioning

confidence: 99%

Health Care Professionals’ Attitudes Toward, and Experiences of Using, a Culture-Sensitive Smartphone App for Women with Gestational Diabetes Mellitus: Qualitative Study

Garnweidner-Holme¹,

Andersen²,

Sando³

et al. 2018

JMIR Mhealth Uhealth

View full text Add to dashboard Cite

show abstract

“…LiP study women without a clinical diagnosis of GDM did not use SMBG, and this might be an important missing factor in our intervention group in this analysis. We have no evidence about which treatment component (diet, exercise, or SMBG) is most effective in reducing complications and regulating blood glucose (15). Similarly, we have only sparse knowledge about which type of exercise is optimal in GDM treatment (16).…”

Section: Discussionmentioning

confidence: 99%

Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP (Lifestyle in Pregnancy) Study

et al. 2018

View full text Add to dashboard Cite

show abstract

“…GDM should be managed by a multidisciplinary team with endocrine and obstetric clinical input as well as diabetes specialist nurses and dieticians. Maternal education is key to good glycaemic control in women with GDM though there remains debate and uncertainty about the most appropriate method and frequency of home glucose monitoring and whether more frequent monitoring by continuous glucose monitoring will have additional benefits 21 . Lifestyle intervention comprising of dietary modification, physical activity and weight management is the first line treatment for GDM.…”

Section: Introductionmentioning

confidence: 99%

Short‐ and long‐term outcomes of gestational diabetes and its treatment on fetal development

Murray

Reynolds

2020

Prenatal Diagnosis

View full text Add to dashboard Cite

Globally the prevalence of gestational diabetes mellitus (GDM) is rising mainly due to the increase in maternal obesity. A number of different methods to screen for and diagnose GDM have been described although consensus on the preferred methods does not yet exist. GDM has significant short‐ and long‐term health risks for the mother, developing fetus and the children born to mothers with GDM. Short‐term risks for the fetus include macrosomia (excessive birthweight), shoulder dystocia, birth trauma, and hypoglycaemia in the immediate postpartum period. Long‐term risks for offspring born to mothers with GDM include increased rates of childhood and adulthood obesity and an increased cardiometabolic risk. A number of pharmacological treatments for GDM have been identified, these include insulin and oral glucose‐lowering drugs metformin and glibenclamide. Whilst these oral glucose‐lowering drugs show similar short‐term childhood outcomes to insulin there is increasing evidence that these drugs may have adverse long‐term outcomes on children and adults exposed to the drugs in utero. Future research on treatments for GDM should include long‐term follow‐ up of children exposed to glucose lowering medication in utero to determine the long‐term cardiometabolic risk in the offspring born to mothers with GDM.

show abstract

Different methods and settings for glucose monitoring for gestational diabetes during pregnancy

Cited by 41 publications

References 72 publications

Health Care Professionals’ Attitudes Toward, and Experiences of Using, a Culture-Sensitive Smartphone App for Women with Gestational Diabetes Mellitus: Qualitative Study

Health Care Professionals’ Attitudes Toward, and Experiences of Using, a Culture-Sensitive Smartphone App for Women with Gestational Diabetes Mellitus: Qualitative Study

Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP (Lifestyle in Pregnancy) Study

Short‐ and long‐term outcomes of gestational diabetes and its treatment on fetal development

Contact Info

Product

Resources

About